Randomized, double blind, placebo control study to evaluate the safety and immunogenicity of CJ-50300 in healthy volunteers : phase I.
Phase of Trial: Phase I
Latest Information Update: 18 Jun 2014
At a glance
- Drugs Smallpox vaccine (Primary)
- Indications Smallpox
- Focus Adverse reactions; Pharmacodynamics
- 12 Oct 2006 New trial record.